San Francisco, CANCT06264843Now EnrollingIRB Ready

Chronic Limb-Threatening Ischemia Clinical Trial in San Francisco, CA

Access cutting-edge chronic limb-threatening ischemia treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by Medistim ASA

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access chronic limb-threatening ischemia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic limb-threatening ischemia treatment provided free

Apply for This San Francisco Location

Check if you qualify for this chronic limb-threatening ischemia clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Chronic Limb-Threatening Ischemia Study in San Francisco

The goal of the study is to identify and validate flow measurement and ultrasound images in patients undergoing vein bypass surgery below-knee and above ankle

Sponsor: Medistim ASA

Who Can Participate

Inclusion Criteria

Chronic Limb-Threatening Ischemia as defined by presence of Peripheral Artery Disease (PAD) in combination with rest pain, gangrene, or a lower limb ulceration\>2 weeks duration (ref Global Guidelines)
Atherosclerotic infra-popliteal PAD
Adequate distal anastomotic target (crural, tibial or popliteal below the knee with one single run-off) between knee and ankle distal to the stenotic/occluded segment.
Available autogenous vein conduit based on preoperative vein mapping.
Understand the nature of the procedure and willingness to comply with protocol. Attend follow-up appointments and provide written informed consent.

Exclusion Criteria

Bypass with artificial conduit or cryopreserved allografts
Bypass for non-atherosclerotic lesions
Life-expectancy less than 2 years
Any psychological, developmental, physical or emotional disorder that the investigator believes would interfere with surgery or follow-up.
Any condition that the investigator believes should exclude participation.
Excessive risk for adverse events during open surgery as judged by the investigator.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT06264843) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Limb-Threatening Ischemia Treatment Options in San Francisco, CA

If you're searching for chronic limb-threatening ischemia treatment options in San Francisco, CA, this clinical trial (NCT06264843) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic limb-threatening ischemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic limb-threatening ischemia clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in San Francisco, CA

See all heart attack clinical trials recruiting in San Francisco — not just this study.

Browse Heart Attack Trials in San Francisco

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA